A high throughput colorimetric cell proliferation assay for the identification of human cytomegalovirus inhibitors.
A colorimetric assay based on the cleavage of the tetrazolium salt WST-1 has been developed for human cytomegalovirus (HCMV) antiviral susceptibility testing and adapted to a microtiter plate format. Optimal conditions were determined and the standard routine assay was calibrated with a viral input of 0.05-0.10 plaque forming unit (p.f.u.)/cell with a density of 2000 cells/well in a 96-well microtiter plate for an incubation period of 7 days. Ganciclovir (9-(2-hydroxy-1(hydroxymethyl) ethyoxymethyl) guanine; DHPG), and cidofovir ((S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine; HPMPC) were used as positive control test compounds to validate the assay. The effective EC50 concentration values obtained with the two antiviral compounds in the present assay were in good agreement with plaque reduction assay results performed in parallel experiments. This method presents the advantage of being easy and rapid to perform, reliable, reproducible, and convenient for use in a high throughput screening capacity.
D000998:Antiviral Agents / Q000494:pharmacology*; D000077404:Cidofovir; D003124:Colorimetry / Q000379:methods; D003587:Cytomegalovirus / Q000187:drug effects* / Q000502:physiology; D003588:Cytopathogenic Effect, Viral; D003596:Cytosine / Q000031:analogs & derivatives / Q000494:pharmacology; D005347:Fibroblasts; D015774:Ganciclovir / Q000494:pharmacology; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods*; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000494:pharmacology; D013778:Tetrazolium Salts / Q000378:metabolism; D014779:Virus Replication / Q000187:drug effects